A bill introduced by Shockat Adam MP proposes a nationally consistent, optometry-led glaucoma testing service in England to shift care from hospitals to community practices.
The Medicine & Healthcare products Regulatory Agency (MHRA) has approved the first licensed low-dose atropine (LDA) treatment for slowing the progression of childhood myopia.